154 related articles for article (PubMed ID: 38353772)
1. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract][Full Text] [Related]
2. Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Lin YY; Hua KQ
Int J Biol Sci; 2018; 14(14):1960-1973. PubMed ID: 30585260
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of long non-coding RNA-based biomarkers in the urinary sediment and urinary exosomes for non-invasive diagnosis of bladder cancer.
Qiu T; Xue M; Li X; Li F; Liu S; Yao C; Chen W
Mol Omics; 2022 Dec; 18(10):938-947. PubMed ID: 36164958
[TBL] [Abstract][Full Text] [Related]
4. Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
Zhan Y; Du L; Wang L; Jiang X; Zhang S; Li J; Yan K; Duan W; Zhao Y; Wang L; Wang Y; Wang C
Mol Cancer; 2018 Sep; 17(1):142. PubMed ID: 30268126
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Annotated and Unannotated Long Noncoding RNAs from Exosome Subtypes Using Next-Generation RNA Sequencing.
Suwakulsiri W; Chen M; Greening DW; Xu R; Simpson RJ
Methods Mol Biol; 2021; 2254():195-218. PubMed ID: 33326077
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
Zhu KR; Sun QF; Zhang YQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MALAT1 from human adipose-derived stem cell exosomes accelerates wound healing via miR-378a/FGF2 axis.
Pi L; Yang L; Fang BR; Meng XX; Qian L
Regen Med; 2022 Sep; 17(9):627-641. PubMed ID: 35822640
[TBL] [Abstract][Full Text] [Related]
9. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway.
Xu J; Xiao Y; Liu B; Pan S; Liu Q; Shan Y; Li S; Qi Y; Huang Y; Jia L
J Exp Clin Cancer Res; 2020 Mar; 39(1):54. PubMed ID: 32209115
[TBL] [Abstract][Full Text] [Related]
10. Advances in the study of exosomal lncRNAs in tumors and the selection of research methods.
Wu Y; Wang Y; Wei M; Han X; Xu T; Cui M
Biomed Pharmacother; 2020 Mar; 123():109716. PubMed ID: 31896067
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
13. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 shuttled by bone marrow-derived mesenchymal stem cells-secreted exosomes alleviates osteoporosis through mediating microRNA-34c/SATB2 axis.
Yang X; Yang J; Lei P; Wen T
Aging (Albany NY); 2019 Oct; 11(20):8777-8791. PubMed ID: 31659145
[TBL] [Abstract][Full Text] [Related]
16. Exosomal MALAT1 derived from ox-LDL-treated endothelial cells induce neutrophil extracellular traps to aggravate atherosclerosis.
Gao H; Wang X; Lin C; An Z; Yu J; Cao H; Fan Y; Liang X
Biol Chem; 2020 Feb; 401(3):367-376. PubMed ID: 31318684
[TBL] [Abstract][Full Text] [Related]
17. EMX2OS Delays Wilms'Tumor Progression via Targeting miR-654-3p.
Chen ZH; Cui MY; Zhang HM
Ann Clin Lab Sci; 2022 Jan; 52(1):12-20. PubMed ID: 35181613
[TBL] [Abstract][Full Text] [Related]
18. Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose derived stem cells, increases dermal fibroblast migration and mitochondrial function.
Kong X; Patel NA; Chalfant CE; Cooper DR
Cell Commun Signal; 2023 Aug; 21(1):221. PubMed ID: 37620957
[TBL] [Abstract][Full Text] [Related]
19. Silencing of lncRNA MEG8 Represses the Viability, Migration, and Invasion of Wilms' Tumor Cells through Mediating miR-23a-3p/CRK Axis.
Shen J; Shu Q
Urol Int; 2022; 106(10):1075-1087. PubMed ID: 34518485
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of long non‑coding RNA using an associated competitive endogenous RNA network in Wilms tumor.
Wang Z; Cheng H; Qi L; Sui D
Mol Med Rep; 2020 Jul; 22(1):105-116. PubMed ID: 32377711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
